Abstract:Objective To compare the serum PSA (T PSA and F/T PSA ratio) between patients of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Methods We studied retrospectively 810 cases of BPH and 103 cases of PCa consecutively from November of 1996 to June of 1999 and compared the differences of T PSA level and F/T ratio between these two kinds of diseases. Results In BPH patients,serum T PSA 4 ng/ml,4～10 ng/ml and 10 ng/ml were 71.7%, 22.1 % and 6.2% respectively while these were 10.7%,17.5% and 71.8% in PCa patients ( P 0.005).When F/T ratio was 0.16,there were significant differences for the component percentages of BPH and PCa cases with the T PSA level 4 or 4～10 ng/ml( P 0.005), whereas there were no differences for those with the T PSA level 10 ng/ml(0.1 P 0.25).When F/T ratio =0.16,its specificity has been 82.2% and its sensitivity 72.4% for distinguishing malignant from benign diseases of the prostate gland. Conclusions There are about 28.0% of BPH and PCa patients with overlapping of T PSA level. When T PSA level ≤10 ng/ml,F/T ratio is of significant value to differentiate PCa from BPH patients, 0.16 (F/T) being a reasonable critical value,whereas F/T is of no significance when T PSA level is 10 ng/ml.

Serum total PSA and the ratio of free to total PSA in patients of benign prostatic hyperplasia and prostate cancer